- Home
- DRUG vs HSTM Comparison
DRUG vs HSTM Comparison
Compare DRUG & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRUG | HSTM |
|---|---|---|
| Founded | 2019 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.9M | 814.2M |
| IPO Year | 2020 | 1999 |
Fundamental Metrics
Financial Performance| Metric | DRUG | HSTM |
|---|---|---|
| Price | $73.10 | $27.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $129.25 | $28.00 |
| AVG Volume (30 Days) | ★ 229.3K | 148.8K |
| Earning Date | 05-15-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $304,064,000.00 |
| Revenue This Year | N/A | $9.45 |
| Revenue Next Year | N/A | $5.12 |
| P/E Ratio | ★ N/A | $140.95 |
| Revenue Growth | N/A | ★ 4.26 |
| 52 Week Low | $32.50 | $19.50 |
| 52 Week High | $123.75 | $30.00 |
Technical Indicators
Market Signals| Indicator | DRUG | HSTM |
|---|---|---|
| Relative Strength Index (RSI) | 49.29 | 52.16 |
| Support Level | $71.39 | $27.63 |
| Resistance Level | $77.16 | $30.00 |
| Average True Range (ATR) | 4.06 | 0.86 |
| MACD | -0.21 | -0.08 |
| Stochastic Oscillator | 30.38 | 48.90 |
Price Performance
Historical ComparisonAbout DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About HSTM HealthStream Inc.
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.